Characteristics of participants previously randomized to either dexamethasone or prednisone
| . | Dexamethasone, n = 51 . | Prednisone, n = 41 . | P . |
|---|---|---|---|
| Age at diagnosis, y, mean (SD) | 3.4 (1.4) | 3.2 (1.0) | .70 |
| Sex, no. (%) | |||
| Female | 21 (41) | 20 (49) | .46 |
| Male | 30 (59) | 21 (51) | |
| Years between diagnosis and start of the study, mean (SD) | 9.8 (0.5) | 9.8 (0.6) | .70 |
| Race/ethnicity, no. (%) | |||
| White, non-Hispanic | 44 (88.0) | 33 (82.5) | .46 |
| Hispanic | 1 (2) | 3 (7.5) | |
| Black, non-Hispanic | 2 (4) | 1 (2.5) | |
| Mixed race and other | 1 (2) | 1 (2.5) | |
| Asian | 2 (4) | 1 (2.5) | |
| Native American | 0 (0) | 1 (2.5) | |
| Marital status of primary caregiver, no. (%) | |||
| Married | 44 (88) | 35 (89.7) | .999 |
| Unmarried | 6 (12) | 4 (10.3) | |
| Education of primary caregiver, no. (%) | |||
| High school or less | 12 (28.0) | 11 (27.5) | .93 |
| Some college | 17 (34.0) | 15 (37.5) | |
| College degree or higher | 19 (38.0) | 14 (35.0) | |
| Family income, no. (%) | |||
| Less than $50 000 | 11 (25.0) | 12 (31.6) | .67 |
| $50 000-$79 999 | 12 (31.8) | 9 (23.7) | |
| $80 000 or more | 19 (43.2) | 17 (44.7) | |
| 6-Mercaptopurine therapy, no. (%) | |||
| Oral | 23 (45.1) | 24 (58.5) | .20 |
| Intravenous | 28 (54.9) | 17 (41.5) |
| . | Dexamethasone, n = 51 . | Prednisone, n = 41 . | P . |
|---|---|---|---|
| Age at diagnosis, y, mean (SD) | 3.4 (1.4) | 3.2 (1.0) | .70 |
| Sex, no. (%) | |||
| Female | 21 (41) | 20 (49) | .46 |
| Male | 30 (59) | 21 (51) | |
| Years between diagnosis and start of the study, mean (SD) | 9.8 (0.5) | 9.8 (0.6) | .70 |
| Race/ethnicity, no. (%) | |||
| White, non-Hispanic | 44 (88.0) | 33 (82.5) | .46 |
| Hispanic | 1 (2) | 3 (7.5) | |
| Black, non-Hispanic | 2 (4) | 1 (2.5) | |
| Mixed race and other | 1 (2) | 1 (2.5) | |
| Asian | 2 (4) | 1 (2.5) | |
| Native American | 0 (0) | 1 (2.5) | |
| Marital status of primary caregiver, no. (%) | |||
| Married | 44 (88) | 35 (89.7) | .999 |
| Unmarried | 6 (12) | 4 (10.3) | |
| Education of primary caregiver, no. (%) | |||
| High school or less | 12 (28.0) | 11 (27.5) | .93 |
| Some college | 17 (34.0) | 15 (37.5) | |
| College degree or higher | 19 (38.0) | 14 (35.0) | |
| Family income, no. (%) | |||
| Less than $50 000 | 11 (25.0) | 12 (31.6) | .67 |
| $50 000-$79 999 | 12 (31.8) | 9 (23.7) | |
| $80 000 or more | 19 (43.2) | 17 (44.7) | |
| 6-Mercaptopurine therapy, no. (%) | |||
| Oral | 23 (45.1) | 24 (58.5) | .20 |
| Intravenous | 28 (54.9) | 17 (41.5) |
Note that some participants declined to report marital status, education, and/or family income.